TABLE 1.
Primer | Sequence (5′→3′)a |
---|---|
RBP-Jκ CpoI, F | aaaCGGTCCGATGGGGGGCTGCAGGAAATTTGGTGA |
RBP-Jκ CpoI, R | aaaCGGACCGTTAGGATACCACTGTGGCTGTAG |
NF-κB1 CpoI, F | aaaCGGTCCGATGGCAGAAGATGATCCATATTTG |
NF-κB1 433 CpoI, R | aaaCGGACCGTTACATGGTTCCATGCTTCATCCCAG |
NF-κB2 CpoI, F | aaaCGGTCCGATGGAGAGTTGCTACAACCCAGGT |
NF-κB2 473 CpoI, R | aaaCGGACCGTTACAGCGCGCGCGCGTCCGCGGTGA |
RelA CpoI, F | aaaCGGTCCGATGGACGATCTGTTTCCCCTCAT |
RelA CpoI, R | aaaCGGACCGTTAGGAGCTGATCTGACTCAAA |
RelB CpoI, F | aaaCGGTCCGATGCCGAGTCGCCGCGCTGCCAG |
RelB CpoI, R | aaaCGGACCGCTACGTGGCTTCAGGCCCTGGA |
c-Rel CpoI, F | aaaCGGTCCGATGGCCTCCGGTGCGTATAACCCGTA |
c-Rel CpoI, R | aaaCGGACCGTTATACTTGAAAAAATTCATATGGAA |
IκBα CpoI, F | aaaCGGTCCGATGTTCCAGGCGGCCGAGCG |
IκBα CpoI, R | aaaCGGACCGTCATAACGTCAGACGCTGGCCTC |
Underlined nucleotides represent restriction enzyme (CpoI) sites used for cloning the PCR products; lowercase letters indicate nucleotides added to enhance recognition by the restriction enzyme. F, forward; R, reverse.